GLPcompare

We built GLPcompare to provide transparent cash pricing and head-to-head clinical trial results for GLP-1 medications across manufacturers, telehealth providers, and pharmacies.

What about reta and other non glp1?

Tracks 58 self-pay offers for Wegovy, Zepbound, Ozempic, Mounjaro, and compounded options with prices checked on the seller's page and dated, next to trial results and FDA shortage status. If you want to spend less on AI at work, take a look at pzero.studio.

Dating each price check is the right call — GLP-1 cash prices seem to move often. How frequently do you re-verify the 58 offers?

This is genuinely useful. Pricing for GLP-1 medications can be confusing, especially when different providers and pharmacies show different offers. Having prices, trial results, and shortage status in one place makes comparison much easier. Nice work on keeping the data transparent and source-checked.

Tracks 58 self-pay offers for Wegovy, Zepbound, Ozempic, Mounjaro, and compounded options with prices checked on the seller's page and dated, next to trial results and FDA shortage status. If you want to spend less on AI at work, take a look at pzero.studio.

Dating each price and linking to the seller's own page is what makes a comparison like this believable. Since offers and shortage status change often, do you re-check on a fixed schedule or when a seller changes something? I would also find it useful to see whether a listed price includes the consultation or medication-only cost, since that is where cash prices tend to confuse people.

Free GLPcompare is a free comparison site for GLP-1 medications in the US. It tracks 58 self-pay offers for Wegovy, Zepbound, Ozempic, Mounjaro, and compounded semaglutide and tirzepatide, from manufacturers, telehealth providers, and pharmacies. Every price is checked on the seller's own page and dated, beside trial results and FDA shortage status.

Really useful concept! Drug pricing and shortage tracking are usually completely opaque, so having this aggregated in one clean UI solves a real headache. Upvoted and congrats on the launch!

The focus on comparing prices, trial results, and shortages addresses a real challenge for people evaluating GLP-1 options. Clear, current comparisons can save a lot of research time.

Pairing cash-price comparison with clinical trial efficacy data is a smart combination — most price tools ignore efficacy and most trial summaries ignore what patients actually pay. The real-time FDA shortage tracking also seems genuinely useful, since GLP-1 availability seems to shift so often. One question: are the 58 self-pay offers refreshed continuously, or updated on a set schedule?

Putting self-pay prices beside trial outcomes and FDA shortage status makes a complicated decision easier to inspect. A timestamp and source link for each offer would make it even easier to verify changes.

Cash-price transparency in this space is genuinely needed, and pairing it with trial efficacy data and FDA shortage status turns a price list into a decision tool. I'm curious how you handle compounded options given the regulatory uncertainty around them - are they marked differently from branded products? And how frequently are the 58 offers re-checked for price accuracy? Congrats on the launch!

Really useful to see self-pay offers dated from the seller's own page. One thing I'd want as a reader: a clear flag for whether the listed price is medication-only or includes the telehealth consult, since those get mixed together a lot in this space.